Pancreatic Polypeptide
Human Pancreatic Polypeptide
36 aa Amino Acids · MW: 4283 Da
Amino Acids
36 aa
Molecular Weight
4283 Da
Half-life
5-10 minutes
Research Score
4.0
Studies
180
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Pancreatic Polypeptide?
Pancreatic polypeptide is a gut-pancreas peptide that can reduce appetite and influence meal size. It has been investigated as a satiety hormone in metabolic and obesity research.
Key Benefits & Mechanisms
reduced hunger
smaller meal size
increased satiety
possible reduction in caloric intake
Research Summary
Human and animal studies show pancreatic polypeptide participates in appetite regulation and may reduce food intake after administration. Its effects are typically short-lived and most evident in controlled meal studies.
Related Peptides
Oxyntomodulin
Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.
Weight ManagementCotadutide
MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.
Weight ManagementMazdutide
IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist
Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.
Weight ManagementDulaglutide
Recombinant GLP-1 receptor agonist Fc fusion protein
Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.
Weight Management